216 related articles for article (PubMed ID: 10976608)
1. Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.
Thiede H; Hagan H; Murrill CS
J Urban Health; 2000 Sep; 77(3):331-45. PubMed ID: 10976608
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
3. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
4. HIV sexual risk behaviors among injection drug users in Shanghai.
Zhao M; Du J; Lu GH; Wang QY; Xu H; Zhu M; McCoy CB
Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S43-7. PubMed ID: 16769445
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
6. Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.
Hagan H; Thiede H
J Urban Health; 2000 Sep; 77(3):369-82. PubMed ID: 10976611
[TBL] [Abstract][Full Text] [Related]
7. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
Liu Y; Liu Y; Zou X; Chen W; Ling L
BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214
[TBL] [Abstract][Full Text] [Related]
8. Syringe exchange and risk of infection with hepatitis B and C viruses.
Hagan H; McGough JP; Thiede H; Weiss NS; Hopkins S; Alexander ER
Am J Epidemiol; 1999 Feb; 149(3):203-13. PubMed ID: 9927214
[TBL] [Abstract][Full Text] [Related]
9. Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users.
Thiede H; Romero M; Bordelon K; Hagan H; Murrill CS
J Urban Health; 2001 Jun; 78(2):264-78. PubMed ID: 11419580
[TBL] [Abstract][Full Text] [Related]
10. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
11. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
12. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
[TBL] [Abstract][Full Text] [Related]
13. Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.
Kuniholm MH; Aladashvili M; Del Rio C; Stvilia K; Gabelia N; Chitale RA; Tsertsvadze T; Nelson KE
Subst Use Misuse; 2008; 43(10):1424-37. PubMed ID: 18696377
[TBL] [Abstract][Full Text] [Related]
14. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
Grau LE; Zhan W; Heimer R
Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
[TBL] [Abstract][Full Text] [Related]
15. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
[TBL] [Abstract][Full Text] [Related]
16. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
17. A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania.
Mlunde LB; Sunguya BF; Mbwambo JK; Ubuguyu OS; Shibanuma A; Yasuoka J; Jimba M
PLoS One; 2016; 11(2):e0148598. PubMed ID: 26849802
[TBL] [Abstract][Full Text] [Related]
18. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
Loewinger G; Sharma B; Karki DK; Khatiwoda P; Kainee S; Poudel KC
Int J Drug Policy; 2016 Jul; 33():75-82. PubMed ID: 27318773
[TBL] [Abstract][Full Text] [Related]
19. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
[TBL] [Abstract][Full Text] [Related]
20. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
